HuGE Literature Finder
Records 1 - 2
| Clinical and Clinical-Pharmacogenetic Models for Prediction of the Most Common Psychiatric Complications Due to Dopaminergic Treatment in Parkinson's Disease.
The international journal of neuropsychopharmacology 2020 7 23 (8): 496-504.
Redenšek Sara, Jenko Bizjan Barbara, Trošt Maja, Dolžan Vi
| Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson's disease.
Journal of neuroinflammation 2019 Feb 16 (1): 50.
Redenšek Sara, Flisar Dušan, Kojovic Maja, Kramberger Milica Gregoric, Georgiev Dejan, Pirtošek Zvezdan, Trošt Maja, Dolžan Vi
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: